정석송 (고려대학교 의과대학)님의 논문 목록 | 한빛사논문 > 한빛사

정석송 님의 논문 목록

고려대학교 의과대학

Pathophysiology, development, and mortality of major non-communicable diseases in metabolic dysfunction-associated steatotic liver disease: A comprehensive review
- Int. J. Biol. Sci., 2025; 21(13):5691-5703 | https://doi.org/10.7150/ijbs.117211
- 2025-09
- 의약학
- 한빛사논문
Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer
- JAMA Netw. Open, Aug 01 2025, 8 (8) | https://doi.org/10.1001/jamanetworkopen.2025.25660
- 2025-08
- 의약학
- 한빛사논문
- 정석송(고려대학교)
[Letter to the Editor] Significant Hepatic Fat Loss after Metabolic Dysfunction-associated Steatotic Liver Disease: Beware of Misclassification as Absence of Disease
- J. Hepatol., Apr 22 2025, S0168-8278(25)00250-8 | https://doi.org/10.1016/j.jhep.2025.04.023
- 2025-04
- 의약학
- 한빛사논문
Young adults with metabolic dysfunction-associated steatotic liver disease have an increased risk of early-onset cancer
- Clin. Gastroenterol. Hepatol., May 08 2025, S1542-3565(25)00338-6 | https://doi.org/10.1016/j.cgh.2025.01.042
- 2025-05
- 의약학
- 한빛사논문
[Correspondence] Reply to "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma"
- Clin. Mol. Hepatol., Jan 06 2025, | https://doi.org/10.3350/cmh.2024.1171
- 2025-01
- 의약학
- 한빛사논문
[Correspondence] Reply to "MAFLD or MASLD: Which Better Represents the Prognosis of the Steatotic Liver Population"
- Clin. Mol. Hepatol., Jan 06 2025, | https://doi.org/10.3350/cmh.2024.1175
- 2025-01
- 의약학
- 한빛사논문
- 정석송(고려대학교)
Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Clin. Mol. Hepatol., Aug 19 2024, | https://doi.org/10.3350/cmh.2024.0323
- 2024-08
- 의약학
- 한빛사논문
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and the risk of hepatocellular carcinoma: a nationwide cohort study
- Clin. Mol. Hepatol., Volume 30(3); Jul 2024 | https://doi.org/10.3350/cmh.2024.0145
- 2024-07
- 의약학
- 한빛사논문
- 정석송(차의과학대학교, 현 고려대학교)
Nutrients associated with metabolic dysfunction-associated steatotic liver disease
- J. Hepatol., Volume 80, Issue 2, February 2024, Pages e81-e82 | https://doi.org/10.1016/j.jhep.2023.09.013
- 2024-02
- 의약학
- 한빛사논문
MASLD and MetALD increase the risk of developing hepatocellular carcinoma and incident or decompensated cirrhosis: a Korean nationwide study
- Liver Cancer, DECEMBER 22 2023 | https://doi.org/10.1159/000535943
- 2023-12
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기